John J. McGovern

2018

In 2018, John J. McGovern earned a total compensation of $742.4K as Former Interim President and CEO CFO and Treasurer at NovaBay Pharmaceuticals, a 64% increase compared to previous year.

Compensation breakdown

Option Awards$422,004
Salary$316,000
Other$4,356
Total$742,360

McGovern received $422K in option awards, accounting for 57% of the total pay in 2018.

McGovern also received $316K in salary and $4.4K in other compensation.

Rankings

In 2018, John J. McGovern's compensation ranked 10,479th out of 14,244 executives tracked by ExecPay. In other words, McGovern earned more than 26.4% of executives.

ClassificationRankingPercentile
All
10,479
out of 14,244
26th
Division
Manufacturing
4,219
out of 5,765
27th
Major group
Chemicals And Allied Products
1,590
out of 2,128
25th
Industry group
Drugs
1,342
out of 1,817
26th
Industry
Pharmaceutical Preparations
1,032
out of 1,391
26th
Source: SEC filing on April 19, 2019.

McGovern's colleagues

We found three more compensation records of executives who worked with John J. McGovern at NovaBay Pharmaceuticals in 2018.

2018

Justin Hall

NovaBay Pharmaceuticals

Chief Executive Officer

2018

Mark Sieczkarek

NovaBay Pharmaceuticals

Chief Executive Officer

2018

Lewis Stuart

NovaBay Pharmaceuticals

Former Chief Commercial Officer

News

In-depth

You may also like